Herpes simplex virus type 1: an atypical presentation of primary infection

Published On 2018-06-02 13:32 GMT   |   Update On 2018-06-02 13:32 GMT

A 3-year-old female child with the history of atopic dermatitis presented with confluent vesicular and shallow ulcers pruritic rash surrounded by an erythematous base located to both hands and wrists, with 1-week evolution. She had no fever or other symptoms. There was no personal or family history of herpetic infections. Topical antibiotic, topical corticosteroid, and oral antihistaminic were tried with no improvement. Physical examination was unremarkable except for generalized dry skin and lesions.


On suspicion of superinfected viral rash or bullous impetigo, she was treated with oral amoxicillin and clavulanic acid (concentration of 250 mg/62.5 mg with the dose of 50 mg/kg/day) and topical fusidic acid. One week later, at re-evaluation, there was a progression of the rash and the mother reported herpes labialis on the father. At this time, the diagnosis of primary eczema herpetic infection was also considered.

Oral acyclovir (20 mg/kg every 6 hours for 5 days) and cefuroxime (30 mg/kg every 12 hours for 7 days) were started, with complete resolution of the lesions after 10 days. PCR assay of lesion’s swab was positive for herpes simplex virus (HSV) type 1 and bacterial culture was negative...

For more details click on the link : doi:10.1136/bcr-2018-224967
Tags:    
Article Source : BMJ Case Reports

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News